Irinotecan/5-FU/FA (I-FU) or 5-FU/FA (FU) first-line therapy in older and younger patients with metastatic colorectal cancer: Combined analysis of 2,691 patients in randomized controlled trials

被引：0
|
作者：
Folprecht, G.
Seymour, M. T.
Saltz, L.
Douillard, J. Y.
Stephens, R. J.
Van Cutsem, E.
Rougier, P.
Maughan, T. S.
Koehne, C. H.
机构：
[1] Univ Hosp Dresden, Dresden, Germany
[2] Cookridge Hosp, Leeds, W Yorkshire, England
[3] Mem Sloan Kettering Canc Ctr, New York, NY USA
[4] Ctr R Gauducheau, Nantes, France
[5] MRC Clin Trials Unit, London, England
[6] Univ Hosp Gasthuisberg, Leuven, Belgium
[7] Hop Ambroise Pare, Boulogne, France
[8] Velindre Hosp, Cardiff, S Glam, Wales
[9] Klinikum Oldenburg GGmbH, Oldenburg, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4071
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Dose escalating study of 5-FU/folinic acid (FA)/oxaliplatin/irinotecan (FOLFOXIRI) and cetuximab in first-line therapy of patients with metastatic colorectal cancer
    Trarbach, T.
    Schuette, K.
    Stoehlmacher, J.
    Goekkurt, E.
    Guenther, H.
    Ubbelohde, U.
    Stroszczynski, C.
    Ehninger, G.
    Folprecht, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] Randomized phase III study of irinotecan and 5-FU/FA with or without cetuximab in the first-line treatment of patients with metastatic colorectal cancer (mCRC): The CRYSTAL trial
    Van Cutsem, E.
    Nowacki, M.
    Lang, I.
    Cascinu, S.
    Shchepotin, I.
    Maurel, J.
    Rougier, P.
    Cunningham, D.
    Nippgen, J.
    Koehne, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] Dose escalating study of cetuximab and 5-FU/folinic acid (FA)/oxaliplatin/irinotecan (FOLFOXIRI) in first line therapy of patients with metastatic colorectal cancer
    Gunnar Folprecht
    Susanne Hamann
    Katharina Schütte
    Tanja Trarbach
    Jan Stoehlmacher-Williams
    Gerhard Ehninger
    BMC Cancer, 14
  • [4] Dose escalating study of cetuximab and 5-FU/folinic acid (FA)/oxaliplatin/irinotecan (FOLFOXIRI) in first line therapy of patients with metastatic colorectal cancer
    Folprecht, Gunnar
    Hamann, Susanne
    Schuete, Katharina
    Trarbach, Tanja
    Stoehlmacher-Williams, Jan
    Ehninger, Gerhard
    BMC CANCER, 2014, 14
  • [5] Cetuximab in combination with irinotecan/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFIRI) in the first-line treatment of metastatic colorectal cancer (mCRC)
    Peeters, M.
    Raoul, J.-L.
    Van Laethem, J.-L.
    Rougier, P.
    Brezault, C.
    Husseini, F.
    Cals, L.
    Zubel, A.
    Vedovato, J.-C.
    EJC SUPPLEMENTS, 2005, 3 (02): : 188 - 188
  • [6] 5-FLUOROURACIL (5-FU) COMBINED WITH LEUCOVORIN (LV) IN PATIENTS WITH ADVANCED 5-FU RESISTANT COLORECTAL-CANCER
    VANGROENINGEN, CJ
    PETERS, GJ
    PINEDO, HM
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 202 - 202
  • [7] SAFETY AND ACTIVITY OF AN ALTERNATINIG REGIMEN OF IRINOTECAN/5-FU/LV AND OXALIPLATIN/5-FU/LV (FAFOXIRI) IN ELDERLY PATIENTS WITH METASTATIC COLORECTAL CANCER (MCC)
    Amoroso, Vito
    Ferrari, Vittorio
    Valcamonico, Francesca
    Vassalli, Lucia
    Simoncini, Edda
    Grisanti, Salvatore
    Marpicati, Patrizia
    Rangoni, Giovanni
    Marini, Giovanni
    ANNALS OF ONCOLOGY, 2004, 15 : 62 - 63
  • [8] Irinotecan/fluorouracil combination in first-line therapy of older and younger patients with metastatic colorectal cancer:: Combined analysis of 2,691 patients in randomized controlled trials
    Folprecht, Gunnar
    Seymour, Matthew T.
    Saltz, Leonard
    Douillard, Jean-Yves
    Hecker, Hartmut
    Stephens, Richard J.
    Maughan, Timothy S.
    Van Cutsem, Eric
    Rougier, Philippe
    Mitry, Emmanuel
    Schubert, Ute
    Koehne, Claus-Henning
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (09) : 1443 - 1451
  • [9] Randomized phase II study of maintenance treatment with 5-FU/FA plus panitumumab vs 5-FU/FA alone after induction (mFOLFOX6 plus panitumumab) in patients with RASWT metastatic colorectal cancer
    Modest, D. P.
    Kasper, S.
    Stintzing, S.
    Prasnikar, N.
    Mueller, L.
    Caca, K.
    Goekkurt, E.
    von Weikersthal, L. Fischer
    Kopp, H. -G.
    Trarbach, T.
    ANNALS OF ONCOLOGY, 2016, 27
  • [10] Multicentre study of irinotecan (CPT-11) combined with 5-FU/FA bolus in the treatment of metastatic colorectal cancer.
    Salvador, J
    Moreno, JA
    Reina, JJ
    Aparicio, J
    Pica, JMP
    Rueda, A
    Lorenzo, A
    de la Puente, CG
    Borrega, P
    Bernabé, R
    ANNALS OF ONCOLOGY, 2000, 11 : 46 - 46
12345